J&J Reports Q3 Results, Adjusts 2026 Outlook

Johnson & Johnson reported third-quarter earnings per share of $2.59, beating analysts’ $2.53 estimate, while revenue of $25.4 billion was slightly above consensus. The company forecast 2026 earnings per share of $10.95–$11.05 and revenue of $101 billion–$101.4 billion, with the earnings outlook below analysts’ estimate. J&J also declared a fourth-quarter 2026 dividend of $1.34 per share, payable December 8 to shareholders of record November 24. Analyst views remain mixed: some firms maintain Buy ratings, while Bank of America has a Hold rating; separate coverage also highlighted insider selling and concerns that the stock may be overvalued.